Qingqing Yang

Lepodisiran — A Long-Duration Small Interfering RNA Targeting Lipoprotein(a)

Applied body-fluid analysis by wearable devices

Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study

Usage and Effectiveness of the Low Glucose Suspend Feature of the Medtronic Paradigm Veo Insulin Pump